Is Tumor Size the Best Predictor of Outcome for Papillary Thyroid Cancer?

By Cheema Yusra   Repplinger Daniel   Elson Diane   Chen Herbert  

Annals of Surgical Oncology, Vol. 13, Iss. 11, 2006-11 ,pp. : 1524-1528

Springer Publishing Company

Access to resources Recommend Favorite

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

By Li Ji-Yu  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 837-848

Springer Publishing Company

Access to resources Recommend Favorite

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

By Cabioglu Neslihan   Sahin Aysegul   Doucet Michele   Yavuz Ekrem   Igci Abdullah   O.Yildirim Engin   Aktas Esin   Bilgic Sema   Kiran Bayram   Deniz Gunnur   Price Janet  

Clinical and Experimental Metastasis, Vol. 22, Iss. 1, 2005-03 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model

By              

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 933-938

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma

By Yip Linwah  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 2035-2041

Springer Publishing Company

Access to resources Recommend Favorite